Insmed (INSM) Return on Invested Capital (2012 - 2026)
Insmed (INSM) posted quarterly Return on Invested Capital of 0.48% for Q1 2026, down 45.0% year-over-year from 0.87% in Q1 2025, and up 1.84% quarter-over-quarter from 0.49% in Q4 2025.
Insmed (INSM) Return on Invested Capital (2012 - 2026) Analysis & Trends
Insmed's Return on Invested Capital history runs 12 years deep, the most recent figure standing at 0.48% for Q1 2026.
- In Q1 2026, Return on Invested Capital fell 45.0% year-over-year to 0.48%; the TTM figure through Mar 2026 stood at 0.48% (down 45.0% YoY), while the FY2025 annual figure was 0.49%, down 18.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.48%, up from 0.49% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.02% in Q3 2024, with the low at 0.49% in Q4 2025.
- The 5-year median for Return on Invested Capital is 0.22% (2023), against an average of 0.2%.
- The sharpest annual moves came in 2024 and 2025: Return on Invested Capital advanced 22 bps in 2024, then slumped 47 bps in 2025.
- Insmed's Return on Invested Capital stood at 0.2% in 2022, then dropped by 17 bps to 0.24% in 2023, then soared by 92 bps to 0.02% in 2024, then slumped by 2550 bps to 0.49% in 2025, then climbed by 2 bps to 0.48% in 2026.
- Business Quant data shows INSM's Return on Invested Capital at 0.48% in Q1 2026, 0.49% in Q4 2025, and 0.43% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.05% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.35% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.35% |
| Mar 31, 2026 | -0.48% |
| Dec 31, 2025 | -0.49% |
| Sep 30, 2025 | -0.43% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.05% |
| Dec 31, 2023 | -0.24% |
| Sep 30, 2023 | -0.22% |
| Jun 30, 2023 | -0.22% |
| Mar 31, 2023 | -0.17% |
| Dec 31, 2022 | -0.20% |
| Sep 30, 2022 | -0.28% |
| Jun 30, 2022 | -0.26% |
| Mar 31, 2022 | -0.26% |
| Dec 31, 2021 | -0.24% |
| Sep 30, 2021 | -0.23% |